摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苄氧羰基-L-酪氨酸苄酯三氟甲烷磺酸酯 | 183070-41-9

中文名称
苄氧羰基-L-酪氨酸苄酯三氟甲烷磺酸酯
中文别名
——
英文名称
L-Nα-Cbz-4-(O-trifluoromethanesulfonate)tyrosine benzyl ester
英文别名
Cbz-Tyr(Tf)-Bzl;Cbz-L-Tyrosine benzyl ester triflate;benzyl (2S)-2-(phenylmethoxycarbonylamino)-3-[4-(trifluoromethylsulfonyloxy)phenyl]propanoate
苄氧羰基-L-酪氨酸苄酯三氟甲烷磺酸酯化学式
CAS
183070-41-9
化学式
C25H22F3NO7S
mdl
——
分子量
537.513
InChiKey
CVDJKKOIYOSXFZ-QFIPXVFZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    648.5±55.0 °C(Predicted)
  • 密度:
    1.387±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    37
  • 可旋转键数:
    12
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    116
  • 氢给体数:
    1
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Practical Method for the Synthesis of Enantiomerically Pure 4-Borono-<b>L</b>-phenylalanine
    作者:Hiroyuki Nakamura、Masaru Fujiwara、Yoshinori Yamamoto
    DOI:10.1246/bcsj.73.231
    日期:2000.1
    Enantiomerically pure L-BPA (4-borono-L-phenylalanine) was synthesized from L-tyrosine or 4-iodo-L-phenylalanine derivatives using the palladium-catalyzed cross-coupling reaction of pinacolborane (2,3-dimethyl-2,3-butanediolatoboron). Cbz-Tyr(Nf)-OBzl (2b) underwent the cross-coupling reaction with pinacolborane (1) in the presence of [PdCl2(PPh3)2] catalyst to give N-benzyloxycarbonyl-4-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3a) in 58% yield. The reaction of the 4-iodo-L-phenylalanine derivatives, such as N-benzyloxycarbonyl-4-iodo-L-phenylalanine benzyl ester (2c), N,N-dibenzyl-4-iodo-L-phenylalanine benzyl ester (2d), (4S)-3-benzyloxycarbonyl-4-(4-iodobenzyl)-5-oxazolidinone (2e), and (4S)-3-t-butyloxycarbonyl-4-(4-iodobenzyl)-5-oxazolidinone (2f), with 1 proceeded very smoothly in the presence of [PdCl2(dppf)] catalyst, giving N-benzyloxycarbonyl-4-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3a), N,N-dibenzyl-4-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3b), (4S)-3-benzyloxycarbonyl-4-[4-(2,3-dimethyl-2,3-butanediolatoboryl)benzyl]-5-oxazolidinone (3c), and (4S)-3-butyloxycarbonyl-4-[4-(2,3-dimethyl-2,3-butanediolatoboryl)benzyl]-5-oxazolidinone (3d), respectively, in high yields. Deprotection of 3a—d gave enantiomerically pure L-BPA in high total yields.
    利用钯催化的频哪醇硼烷(2,3-二甲基-2,3-丁二醇硼)交叉偶联反应,从 L-酪氨酸或 4-碘-L-苯丙氨酸衍生物合成了对映体纯度极高的 L-BPA(4-硼-L-苯丙氨酸)。在[PdCl2(PPh3)2]催化剂存在下,Cbz-Tyr(Nf)-OBzl (2b) 与频哪醇硼烷 (1) 发生交叉偶联反应,得到 N-苄氧羰基-4-(2,3-二甲基-2,3-丁二醇基)-L-苯丙氨酸苄酯 (3a),收率为 58%。4-碘-L-苯丙氨酸衍生物的反应,如 N-苄氧羰基-4-碘-L-苯丙氨酸苄酯 (2c)、N,N-二苄基-4-碘-L-苯丙氨酸苄酯 (2d)、(4S)-3-苄氧羰基-4-(4-碘苄基)-5-恶唑烷酮(2e)和(4S)-3-叔丁氧羰基-4-(4-碘苄基)-5-恶唑烷酮(2f),其中 1 在[PdCl2(dppf)]催化剂存在下进行得非常顺利、得到 N-苄氧羰基-4-(2,3-二甲基-2,3-丁二醇二硼酸基)-L-苯丙氨酸苄酯 (3a)、N,N-二苄基-4-(2,3-二甲基-2,3-丁二醇二硼酸基)-L-苯丙氨酸苄酯 (3b)、(4S)-3-苄氧羰基-4-[4-(2、3-(2,3-二甲基-2,3-丁二醇基)苄基]-5-恶唑烷酮 (3c) 和 (4S)-3-丁酰氧羰基-4-[4-(2,3-二甲基-2,3-丁二醇基)苄基]-5-恶唑烷酮 (3d)。对 3a-d 进行脱保护处理后,可得到对映体纯度很高的 L-BPA,总产率也很高。
  • Synthesis of novel L-phenylalanine derivatives substituted with a keto ylide as stable precursor of a vicinal tricarbonyl moiety
    作者:Heinz Fretz
    DOI:10.1016/0040-4039(96)01978-8
    日期:1996.11
    Novel L-phenylalanine derivatives 5 containing a vicinal tricarbonyl moiety at the para position of the phenyl ring were prepared in 4 steps starting from Nα-Cbz-L-tyrosine benzyl ester. A 7 step reaction sequence lead to Nα-Fmoc protected derivatives 9 with the tricarbonyl structure masked as its stable keto ylide precursor, which is suitable for solid phase peptide synthesis. The phosphoranylidene
    新颖的L-苯丙氨酸衍生物5在苯基环的对位含有邻位三羰基部分在制备4个选自N开始步骤α -Cbz -L-酪氨酸苄酯。A 7步骤反应顺序导致Ñ α -Fmoc保护的衍生物9与掩蔽为它的稳定的酮前体叶立德,其适合于固相肽合成的三羰基结构。的正膦基亚基中间体8转化到三氧代化合物5与过硫酸氢钾®作为氧化剂
  • The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: A proof-of-concept study
    作者:Julien Chapelat、Frédéric Berst、Andreas L. Marzinzik、Henrik Moebitz、Peter Drueckes、Joerg Trappe、Doriano Fabbro、Dieter Seebach
    DOI:10.1016/j.ejmech.2012.08.038
    日期:2012.11
    Protein kinases are widely recognized as important therapeutic targets due to their involvement in signal transduction pathways. These pathways are tightly controlled and regulated, notably by the ability of kinases to selectively phosphorylate a defined set of substrates. A wide variety of disorders can arise as a consequence of abnormal kinase-mediated phosphorylation and numerous kinase inhibitors have earned their place as key components of the modern pharmacopeia. Although "traditional" kinase inhibitors typically act by preventing the interaction between the kinase and ATP, thus stopping substrate phosphorylation, an alternative approach consists in disrupting the protein protein interaction between the kinase and its downstream partners. In order to facilitate the identification of potential chemical starting points for substrate-site inhibition approaches, we desired to investigate the application of Substrate Activity Screening to kinases. We herein report a proof-of-concept study demonstrating, on a model tyrosine kinase, that the key requirements of this methodology can be met. Namely, using peptides as model substrates, we show that a simple ADP-accumulation assay can be used to monitor substrate efficiency and that efficiency can be optimized in a modular manner. More importantly, we demonstrate that structure efficiency relationships translate into structure activity relationships upon conversion of the substrates into inhibitors. (C) 2012 Elsevier Masson SAS. All rights reserved.
  • A Concise Synthesis of Enantiomerically Pure <scp>l</scp>-(4-Boronophenyl)alanine from <scp>l</scp>-Tyrosine
    作者:Hiroyuki Nakamura、Masaru Fujiwara、Yoshinori Yamamoto
    DOI:10.1021/jo980818r
    日期:1998.10.1
  • Preparation of l-Nα-Fmoc-4-[di-(tert-butyl)phosphonomethyl]phenylalanine from l-tyrosine
    作者:Zhu-Jun Yao、Yang Gao、Terrence R Burke
    DOI:10.1016/s0957-4166(99)00385-7
    日期:1999.9
    The unnatural amino acid analogue, 4-(phosphonomethyl)phenylalanine (Pmp, 2), has proven to be a valuable tool for studying protein-tyrosine kinase dependent signal transduction, where it is most often incorporated into peptides or peptide mimetics as a phosphatase-stable phosphotyrosyl mimetic. Although Pmp has been prepared previously bearing a number of protection strategies, the N-alpha-Fmoc 4- [di-(tert-butyl)phosphonomethyl] phenylalanine form [(N alpha-Fmoc-L-Pmp('Bu-2)-OH, 3] is particularly attractive since it can be cleanly introduced into peptides using standard Fmoc protocols. Synthesis of 3 was first reported as its (D/L)-racemate, and subsequently as its L-3 enantiomer, with the latter synthesis having relied on induction of chirality using a camphor sultam auxiliary. Reported herein is an alternate enantioselective synthesis of L-3 in high ensantiomeric purity by procedures which derive the stereochemistry of the final product directly from the starting amino acid, without the need for chiral induction. A key feature of the route is the racemization-free nucleophilic substitution of lithium di-tert-butyl phosphite onto protected 4-bromomethylphenylalanine (17). (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物